http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106267405-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3693 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3621 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-3601 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36 |
| filingDate | 2016-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106267405-B |
| titleOfInvention | Female tire blood group incompatibility haemolysis disease therapeutic apparatus |
| abstract | The present invention relates to medical domain mother's tire blood group incompatibility haemolysis disease therapeutic apparatus, it is characterized in that Rh positive red blood cell is removed the hemoglobin of toxic side effect with PB lysate thoroughly but retains only ghost of the absorption Rh antibody without adsorbing other blood group antibodies, it is fixed on the agarose of special concentration with specific proportion jointly with the anti-Rh antibody prepared with immunology, it is followed by the package of hydrostatic column made of high-biocompatibility material, it is allowed to form antibody titer from high to low from sample introduction end to sample outlet end and agarose concentration but ghost from low to high is to be uniformly distributed, and nearly sample outlet end due to concentration is gradually high molecule micropore gradually small special concentration agarose can effectively detention Hemolysis erythrocyte be destroyed be formed by fragment and it is in combination made of macromolecular immune complex, it is that one kind only removes pathogenic antibody, it does not remove The treatment new method for the female tire Rh blood group incompatibility Hemolysis of blood plasma components having no toxic side effect. |
| priorityDate | 2016-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.